http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H0267293-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6b55c79232b7a82f550a37f71412452f
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7042
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7048
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H17-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
filingDate 1988-09-01^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c161f4884bcdba1dc5a4ad6adbcafbde
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2dc621dc631e6904849f483007575c0d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d39883775a444ab321d24636fc584fc7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_45194903980fab2639e7b8e5af897ed2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b3031c54865d114c976ef277a29f3fee
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6f9c8e68fab8b29a27eddb050424379a
publicationDate 1990-03-07^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-H0267293-A
titleOfInvention Production of 6-0-substituted chartreusin derivative
abstract PURPOSE: To obtain the subject compound useful as anticancer drug or intermediate of said drug in high yield and high purity by reacting chartreusin with acyl halide in the presence of strong basic substance having dehydrohalogenating action. n CONSTITUTION: Chartreusin or 3',4'-O-benzylidene chartreusin is reacted with acyl halide in the presence of strong basic substance having dehydrohalogenating action (preferably triethylamine or 1,8-diazabicyclo[5.4.0]undecene-7) to obtain the aimed compound. Besides, chartreusin is usually dissolved in solvent such as benzene, etc., and basic substance is added, then acyl halide is added, thus the reaction is performed. Further, reaction temperature is preferably from from -5°C to 30°C. n COPYRIGHT: (C)1990,JPO&Japio
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0614909-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0614909-A3
priorityDate 1988-09-01^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S6299391-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5351130
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID241
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426067745
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395324
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID81184
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8471
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5281394
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID227231573
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419553602
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5487106
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559219
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID227231574
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426089024

Showing number of triples: 1 to 35 of 35.